Hypoxia-tuned regulatory T cells as a programmable “tolerance switch”

Multiple lines of work point to context-dependent Treg states. Single-cell analyses in pancreatic cancer suggest that the HIF-1 pathway helps split Tregs into phenotypes with opposing prognostic associations (Xu et al., 2023), and reviews increasingly emphasize tissue-specific, non-suppressive Treg functions (Jugder et al., 2025) and the difficulty of targeting Tregs in tumors without breaking self-tolerance (Li et al., 2020; Zhang et al., 2024). Building on these tensions, this project proposes a “hypoxia-tuned” Treg system: (i) map oxygen-dependent Treg transcriptional programs across tissues using single-cell multi-omics and spatial oxygen profiling; (ii) identify HIF-1–responsive levers (e.g., glycolysis vs fatty-acid oxidation bias, CTLA-4/IL-10 expression, adenosinergic pathways) that correlate with suppressive potency; and (iii) create synthetic oxygen-sensing circuits in Tregs (HRE-driven control of key suppressive modules) or small-molecule regimens that bias endogenous Tregs to be maximally suppressive in normoxia but attenuated in hypoxia. This diverges from standard Treg expansion or depletion by adding a spatial-metabolic gate that respects tumor hypoxia. If successful, it would allow strong local tolerance in autoimmune disease and transplantation while minimizing tumor-protective Treg activity—a long-standing challenge highlighted by Sakaguchi et al. (2008), Li et al. (2020), and Zhang et al. (2024).

References:

1. Regulatory T Cells and Immune Tolerance. S. Sakaguchi, Tomoyuki Yamaguchi, T. Nomura, M. Ono (2008). Cell.
2. Regulatory T cells in immune checkpoint blockade antitumor therapy. An Zhang, Tao Fan, Yixiao Liu, Guanhua Yu, Chunxiang Li, Zheng Jiang (2024). Molecular Cancer.
3. Tissue-specific roles of regulatory T cells: mechanisms of suppression and beyond along with emerging therapeutic insights in autoimmune indications. B. Jugder, Eunchong Park, Lijuan Du, Chetan Jawale, Nikolay Popov, Zengli Guo, Kyle J. Bednar, T. Ort (2025). Frontiers in Immunology.
4. Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects. Chunxiao Li, P. Jiang, Shuhua Wei, Xiaofei Xu, Junjie Wang (2020). Molecular Cancer.
5. Unveiling the role of regulatory T cells in the tumor microenvironment of pancreatic cancer through single-cell transcriptomics and in vitro experiments. Wei Xu, Wenjia Zhang, Dongxu Zhao, Qi Wang, Man Zhang, Qiang Li, Wenxin Zhu, Chunfang Xu (2023). Frontiers in Immunology.